Stockscreener 앱 받기
19.97
1.47%
0.29
시간 외 거래:
19.58
-0.39
-1.95%
전일 마감가:
$19.68
열려 있는:
$19.81
하루 거래량:
556.12K
Relative Volume:
1.14
시가총액:
$1.08B
수익:
$2.22M
순이익/손실:
$-40.51M
주가수익비율:
-15.54
EPS:
-1.2847
순현금흐름:
$-46.53M
1주 성능:
+16.58%
1개월 성능:
+28.84%
6개월 성능:
+135.77%
1년 성능:
+0.00%
1일 변동 폭
$19.09
$20.42
1주일 범위
$16.66
$21.03
52주 변동 폭
$5.14
$29.46
Upstream Bio Inc Stock (UPB) Company Profile
명칭
Upstream Bio Inc
전화
781-208-2466
주소
890 WINTER STREET, SUITE 200, WALTHAM
UPB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UPB
Upstream Bio Inc
|
19.97 | 1.06B | 2.22M | -40.51M | -46.53M | -1.2847 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Upstream Bio Inc Stock (UPB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-05 | 개시 | JP Morgan | Overweight |
| 2024-11-05 | 개시 | Piper Sandler | Overweight |
| 2024-11-05 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 개시 | William Blair | Outperform |
Upstream Bio Inc 주식(UPB)의 최신 뉴스
Statistical indicators supporting Upstream Bio Inc.’s strength2025 Analyst Calls & Technical Confirmation Trade Alerts - Newser
Using portfolio simulators with Upstream Bio Inc. included2025 Buyback Activity & Expert Verified Stock Movement Alerts - Newser
How to interpret RSI for Upstream Bio Inc. stock2025 Market Sentiment & Safe Entry Trade Reports - Newser
Upstream Bio’s Phase 2 VIBRANT Trial Results and Strategic Implications for Long-Term Growth - AInvest
Is Upstream Bio Inc. stock poised for growthMarket Performance Summary & Consistent Profit Focused Trading Strategies - Newser
Is now a turning point for Upstream Bio Inc.Portfolio Gains Report & Accurate Buy Signal Notifications - Newser
Will Upstream Bio Inc. benefit from geopolitical trendsJuly 2025 Catalysts & Short-Term Swing Trade Alerts - خودرو بانک
Can Upstream Bio Inc. outperform in the next rally2025 Trading Volume Trends & AI Powered Buy and Sell Recommendations - خودرو بانک
Long term hold vs stop loss in Upstream Bio Inc.Price Action & Free Technical Confirmation Trade Alerts - Newser
Is Upstream Bio Inc. stock a top performer YTDWeekly Trend Report & Free Safe Capital Growth Stock Tips - خودرو بانک
Upstream Bio Inc. stock momentum explainedForecast Cut & Daily Risk Controlled Trade Plans - Newser
Transcript : Upstream Bio, Inc.Special Call - MarketScreener
Is Upstream Bio Inc. forming a bottoming baseJuly 2025 Market Mood & Real-Time Stock Movement Alerts - Newser
Trend analysis for Upstream Bio Inc. this weekPortfolio Growth Summary & Real-Time Chart Pattern Alerts - Newser
Using economic indicators to assess Upstream Bio Inc. potentialJuly 2025 Retail & AI Enhanced Trade Execution Alerts - Newser
Technical signs of recovery in Upstream Bio Inc.2025 Breakouts & Breakdowns & AI Powered Market Entry Strategies - Newser
Exit strategy if you’re trapped in Upstream Bio Inc.Trade Entry Summary & Verified Short-Term Plans - Newser
Upstream Bio Initiates Phase 2 Clinical Trial for COPD Drug, Verekitug - MSN
What MACD and RSI say about Upstream Bio Inc.2025 Major Catalysts & AI Powered Buy/Sell Recommendations - Newser
How to build a dashboard for Upstream Bio Inc. stock2025 Top Gainers & Fast Gain Stock Tips - Newser
Real time breakdown of Upstream Bio Inc. stock performanceMarket Performance Recap & High Accuracy Swing Entry Alerts - Newser
Analyzing Upstream Bio Inc. with risk reward ratio chartsWeekly Profit Analysis & High Conviction Buy Zone Alerts - Newser
Does Upstream Bio Inc. offer margin of safetyMarket Risk Report & Capital Efficiency Focused Strategies - خودرو بانک
Will Upstream Bio Inc. outperform during market ralliesMarket Sentiment Report & Daily Entry Point Trade Alerts - خودرو بانک
Upstream Bio Inc. stock outlook for YEAR2025 Momentum Check & High Win Rate Trade Alerts - Newser
Is Upstream Bio Inc. a strong candidate for buy and holdQuarterly Trade Review & Reliable Breakout Stock Forecasts - خودرو بانک
Upstream Bio Announces Positive Phase 2 Trial Results - The Globe and Mail
Developing predictive dashboards with Upstream Bio Inc. dataRate Cut & Technical Pattern Recognition Alerts - Newser
Is Upstream Bio Inc. meeting your algorithmic filter criteriaDay Trade & Free Community Consensus Stock Picks - Newser
Upstream Bio shares rise 1.18% premarket after reporting positive top-line results from the Phase 2 VIBrant trial of Verekitug for the treatment of chronic rhinosinusitis with nasal polyps. - AInvest
Upstream Bio, Inc. $UPB Shares Sold by Charles Schwab Investment Management Inc. - Defense World
Signal strength of Upstream Bio Inc. stock in tech scannersRecession Risk & Low Drawdown Investment Ideas - Newser
Upstream Bio Reports Positive Top-Line Results from the - GlobeNewswire
Upstream Bio Shares Surge 18.27% on Strong Phase 2 Trial Data for Verekitug - AInvest
Technical Heatmap Flags Upstream Bio Inc. for WatchCPI Data & Safe Entry Zone Tips - beatles.ru
Verekitug heads to late-stage trials after Phase II success - Yahoo Finance
Upstream's New Sinus Treatment Cuts Need For Surgery, Early Trial FindsUpstream Bio (NASDAQ:UPB) - Benzinga
Upstream Bio’s Phase 2 win could set it up as a potential Dupixent, Tezspire competitor - Endpoints News
Positive Buy Rating for Upstream Bio, Inc. Driven by Promising Clinical Trial Results for Verekitug - TipRanks
Upstream Bio Reports Positive Top-line Results From Phase 2 VIBRANT Study - Nasdaq
Upstream Bio Inc (UPB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):